Gyre Therapeutics Inc [GYRE] stock is trading at $11.90, down -2.46%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GYRE shares have gain 7.01% over the last week, with a monthly amount glided 5.40%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Piper Sandler started tracking the stock with Overweight rating on February 10, 2021, and set its price target to $15. On May 21, 2020, Raymond James initiated with a Outperform rating and assigned a price target of $20 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $24 on January 04, 2019. B. Riley FBR Inc. reiterated its recommendation of a Buy and raised its price target to $49 on February 12, 2018. Chardan Capital Markets reiterated a Buy rating for this stock on February 09, 2018, and upped its price target to $75. In a note dated February 09, 2018, Chardan Capital Markets reiterated an Buy rating on this stock and boosted its target price from $10 to $75.
Gyre Therapeutics Inc [GYRE] stock has fluctuated between $8.26 and $30.39 over the past year. Gyre Therapeutics Inc [NASDAQ: GYRE] shares were valued at $11.90 at the most recent close of the market.
Analyzing the GYRE fundamentals
Gross Profit Margin for this corporation currently stands at 0.96% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at -0.22%, and Net Profit Margin reading is -0.33%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.63 and Total Capital is 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.70 points at the first support level, and at 11.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.16, and for the 2nd resistance point, it is at 12.41.
Ratios To Look Out For
For context, Gyre Therapeutics Inc’s Current Ratio is 3.72. As well, the Quick Ratio is 3.29, while the Cash Ratio is 1.08.
Transactions by insiders
Recent insider trading involved Ma Songjiang, President, that happened on Dec 20 ’24 when 2000.0 shares were sold. President, Ma Songjiang completed a deal on Dec 19 ’24 to sell 2000.0 shares. Meanwhile, President Ma Songjiang sold 2000.0 shares on Dec 18 ’24.
